DNMT1 and neoplasm: These results demonstrate that while 5-azacytidine treatment reduced tumour cell viability at higher doses, a prolonged low-dose approach can effectively reduce DNMT levels and cause DNA demethylation without causing major alterations in cell viability, thus setting the stage for exploration of a combinatorial treatment strategy.